Literature DB >> 25093105

Individualized altered fractionation as a more effective radiotherapy for non-small cell lung cancer.

Yi-Jen Chen1.   

Abstract

Entities:  

Year:  2014        PMID： 25093105      PMCID： PMC4120184          DOI： 10.3978/j.issn.2072-1439.2014.06.39

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  1 in total

1.  Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

Authors:  Audrey Mauguen; Cécile Le Péchoux; Michele I Saunders; Steven E Schild; Andrew T Turrisi; Michael Baumann; William T Sause; David Ball; Chandra P Belani; James A Bonner; Aleksander Zajusz; Suzanne E Dahlberg; Matthew Nankivell; Sumithra J Mandrekar; Rebecca Paulus; Katarzyna Behrendt; Rainer Koch; James F Bishop; Stanley Dische; Rodrigo Arriagada; Dirk De Ruysscher; Jean-Pierre Pignon
Journal:  J Clin Oncol       Date:  2012-07-02       Impact factor: 44.544
  1 in total
  2 in total

1.  Effect of rapamycin (RAPA) on the growth of lung cancer and its mechanism in mice with A549.

Authors:  Linmei Wang; Ruiling Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells.

Authors:  Lei Bi; Xiaojing Yan; Ye Yang; Lei Qian; Yuan Tian; Jian-Hua Mao; Weiping Chen
Journal:  Oncotarget       Date:  2017-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.